Vancouver, BC, December 17, 2020--TRIUMF, Canada's particle accelerator centre, announced it has entered into a collaboration agreement with Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.

Vancouver, BC, October 25, 2019--TRIUMF, Canada's particle accelerator centre, and Canadian Nuclear Laboratories (CNL), Canada's premier nuclear science and technology organization, announced that they have completed the first joint production run of actinium-225, a rare medical isotope that shows great promise as the basis for new, cutting-edge cancer therapies.

Vancouver, BC, April 4, 2019--CDRD, Canada's life sciences venture, TRIUMF, the country's national particle accelerator centre, and TRIUMF Innovations, the centre's commercialization arm announced that they have joined forces to advance and commercialize promising research in the field of novel radiopharmaceuticals.

Vancouver, BC, June 26, 2018--Canada to lead 'coldbox' technology for High-Luminosity LHC upgrade with $10M from Government of Canada

Vancouver, BC, January 12, 2018--TRIUMF: Another year, another scientific breakthrough, and the latest from the ALPHA Collaboration could be its most important yet. Released last month in the prestigious journal Nature, the collaboration reports on the first spectroscopic measurement of an atom of antimatter using lasers.

Vancouver, BC, September 23, 2016--A consortium of institutions led by TRIUMF, Canada's national laboratory for particle and nuclear physics and accelerator-based science, is granting sole rights for its proprietary technetium-99m (Tc-99m) production technology to ARTMS™ Products, Inc (ARTMS).